S. Stanton

发表

Rybp interacts with Hippi and enhances Hippi-mediated apoptosis

J. Locker, N. Schreiber-Agus, S. Stanton, 2007, Apoptosis.

Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays

Eric S. Lander, Thomas J. Hudson, David M. Tanenbaum, 2000, Nature Biotechnology.

Designing vaccines to prevent breast cancer recurrence or invasive disease.

M. Disis, S. Stanton, 2015, Immunotherapy.

Current methods of epitope identification for cancer vaccine design.

M. Disis, S. Stanton, G. Cherryholmes, 2015, Vaccine.

Concurrent SPECT/PET-CT imaging as a method for tracking adoptively transferred T-cells in vivo

D. Mankoff, J. Eary, M. Disis, 2016, Journal of Immunotherapy for Cancer.

Micrometastases?Immunity to Breast Cancer Eliminate Residual

M. Disis, S. Stanton, 2014 .

Can Immunity to Breast Cancer Eliminate Residual Micrometastases?

M. Disis, S. Stanton, 2013, Clinical Cancer Research.

Micrometastases ? Can Immunity to Breast Cancer Eliminate Residual Updated

M. Disis, S. Stanton, 2013 .

Development and therapeutic manipulation of the head and neck cancer tumor environment to improve clinical outcomes

R. Leidner, S. Stanton, M. Gough, 2022, Frontiers in Oral Health.

Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity

P. Christos, L. Vahdat, E. Chuang, 2015, BMC Cancer.

Breast cancer: What lies beyond APHINITY for HER2-positive breast cancer?

N. Davidson, S. Stanton, 2017, Nature Reviews Clinical Oncology.

Immunotherapy in breast cancer: An introduction.

M. Disis, S. Stanton, 2018, Breast.

Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients

S. Hanash, Hiroyuki Katayama, James E. Annis, 2021, npj Breast Cancer.

The Antigenic Repertoire of Premalignant and High-Risk Lesions

M. Disis, S. Stanton, J. Marquez, 2015, Cancer Prevention Research.

Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes: A Systematic Review.

S. Adams, M. Disis, Mary L Disis, 2016, JAMA oncology.

Clinical significance of tumor-infiltrating lymphocytes in breast cancer

M. Disis, S. Stanton, 2016, Journal of Immunotherapy for Cancer.

Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates

James Y. Dai, A. Tinker, B. Goff, 2021, Journal for ImmunoTherapy of Cancer.

Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets.

Hailing Lu, M. Disis, S. Stanton, 2019, Vaccine.

Yaf2 Inhibits Caspase 8-mediated Apoptosis and Regulates Cell Survival during Zebrafish Embryogenesis*

N. Schreiber-Agus, L. J. McReynolds, T. Evans, 2006, Journal of Biological Chemistry.

Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients

S. Hanash, Hiroyuki Katayama, James E. Annis, 2021, npj Breast Cancer.

Natural history of tumor growth and immune modulation in common spontaneous murine mammary tumor models

P. Treuting, M. Disis, S. Stanton, 2014, Breast Cancer Research and Treatment.

Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer

S. Hanash, Hailing Lu, M. Disis, 2014, Journal of Translational Medicine.

Immunologic Approaches to Breast Cancer Therapy

M. Disis, S. Stanton, E. Ramos, 2018 .

Triple-negative breast cancer: immune modulation as the new treatment paradigm.

M. Disis, Mary L Disis, S. Stanton, 2015, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer

S. Hanash, M. Disis, S. Stanton, 2013, Journal of Immunotherapy for Cancer.

Recurrent allelic deletions of chromosome arms 15q and 16q in human small cell lung carcinomas

M. Meyerson, S. Stanton, B. Johnson, 2000, Genes, chromosomes & cancer.

Changing trends and disparities in 5-year overall survival of women with invasive breast cancer in the United States, 1975-2015.

Yibin Kang, Wenwei Hu, B. Haffty, 2021, American journal of cancer research.

Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer

S. Hanash, Hailing Lu, M. Disis, 2014, Journal of Translational Medicine.

Associations of Multiparametric Breast MRI Features, Tumor-Infiltrating Lymphocytes, and Immune Gene Signature Scores Following a Single Dose of Trastuzumab in HER2-Positive Early-Stage Breast Cancer

Anum S. Kazerouni, S. Partridge, V. Gadi, 2023, Cancers.

Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report

R. Shoemaker, E. Jaffee, J. Schlom, 2022 .

The Antigenic Repertoire of Premalignant and High-Risk Lesions

M. Disis, S. Stanton, J. Marquez, 2015, Cancer Prevention Research.

546 A phase I dose escalation study of STEMVAC, a multi-antigen, multi-epitope Th1 selective plasmid-based vaccine, targeting stem cell associated proteins in patients with advanced breast cancer

M. Disis, D. Cecil, S. Stanton, 2022, Regular and Young Investigator Award Abstracts.

Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report

R. Shoemaker, E. Jaffee, J. Schlom, 2021, Journal of cancer prevention.

Advances and challenges in cancer immunoprevention and immune interception

S. Stanton, Olivera J Finn, Leisha A Emens, 2024, Journal for ImmunoTherapy of Cancer.